Aptamer Sciences Inc

CHOOLIP & SCIENCES Inc. is a bio venture company focused on an aptamer technology platform for developing therapeutics and diagnostics. Its platforms cover aptamer discovery and optimization, as well as therapeutics and diagnostics for cancer and neurological disorders. Its offerings include the AlloMAp and Bi-Functional Aptamer (BiFAp) therapeutic platform programs and Aptodetect-lung, an early diagnosis kit for lung cancer. Formerly known as Aptamer Sciences Inc., it changed its name to CHOOLIP & SCIENCES Inc. in August 2026; it was founded in 2011 and is headquartered in Seongnam-si, South Korea.